SVB Leerink Upgrades Pacira Pharmaceuticals (PCRX) to Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Pacira Pharmaceuticals (PCRX) PT Lowered to $53 at Jefferies
March 24, 2020 5:27 AM EDTJefferies analyst David Steinberg lowered the price target on Pacira Pharmaceuticals (NASDAQ: PCRX) to $53.00 (from $67.00) while maintaining a Buy rating.
... More